Madeline B. Torres

623 total citations
24 papers, 290 citations indexed

About

Madeline B. Torres is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Madeline B. Torres has authored 24 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 9 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Madeline B. Torres's work include Pancreatic and Hepatic Oncology Research (6 papers), CAR-T cell therapy research (5 papers) and Neuroendocrine Tumor Research Advances (2 papers). Madeline B. Torres is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), CAR-T cell therapy research (5 papers) and Neuroendocrine Tumor Research Advances (2 papers). Madeline B. Torres collaborates with scholars based in United States, China and Puerto Rico. Madeline B. Torres's co-authors include Amalia Cochran, Arghavan Salles, Enrique Meléndez, R. Pomés Hernández, Niraj J. Gusani, Matthew Dixon, Chan Shen, Nan Li, Mitchell Ho and Natalia de Val and has published in prestigious journals such as Cancer Research, The American Journal of Surgery and Journal of the American College of Surgeons.

In The Last Decade

Madeline B. Torres

21 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madeline B. Torres United States 7 134 124 76 58 39 24 290
Jordan T. Said United States 10 70 0.5× 103 0.8× 47 0.6× 91 1.6× 60 1.5× 30 399
Maria C. Bishop United States 8 66 0.5× 112 0.9× 54 0.7× 121 2.1× 42 1.1× 16 450
Suneela Vegunta United States 10 160 1.2× 154 1.2× 78 1.0× 66 1.1× 29 0.7× 38 421
Omofolasade Kosoko‐Lasaki United States 10 121 0.9× 133 1.1× 68 0.9× 38 0.7× 37 0.9× 20 435
Doris Browne United States 7 41 0.3× 60 0.5× 59 0.8× 120 2.1× 21 0.5× 11 324
Vaidehi Agrawal United States 12 106 0.8× 106 0.9× 179 2.4× 22 0.4× 11 0.3× 34 452
Morgan Bonds United States 7 48 0.4× 78 0.6× 62 0.8× 45 0.8× 90 2.3× 20 319
Madalene A. Earp Canada 10 111 0.8× 150 1.2× 46 0.6× 40 0.7× 14 0.4× 27 302
Diana Harris United States 6 62 0.5× 116 0.9× 62 0.8× 29 0.5× 41 1.1× 8 323
Lauren M. Theiss United States 10 29 0.2× 77 0.6× 126 1.7× 47 0.8× 39 1.0× 20 396

Countries citing papers authored by Madeline B. Torres

Since Specialization
Citations

This map shows the geographic impact of Madeline B. Torres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madeline B. Torres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madeline B. Torres more than expected).

Fields of papers citing papers by Madeline B. Torres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madeline B. Torres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madeline B. Torres. The network helps show where Madeline B. Torres may publish in the future.

Co-authorship network of co-authors of Madeline B. Torres

This figure shows the co-authorship network connecting the top 25 collaborators of Madeline B. Torres. A scholar is included among the top collaborators of Madeline B. Torres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madeline B. Torres. Madeline B. Torres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Torres, Madeline B., Jessica E. Maxwell, Rebecca A. Snyder, et al.. (2024). Total Venous Control and Vein-to-the-Right Superior Mesenteric Artery Approach in Robotic Pancreatoduodenectomy. Annals of Surgical Oncology. 31(13). 8721–8722. 1 indexed citations
3.
Johnson, Helen M., Madeline B. Torres, Mecker G. Möller, et al.. (2023). Association of Women Surgeons’ Comprehensive Initiative for Healthy Surgical Families During Residency and Fellowship Training. JAMA Surgery. 158(3). 310–310. 12 indexed citations
4.
Torres, Madeline B., Élise Schaefer, Neekita Jikaria, Gail Ortenzi, & Amanda Cooper. (2022). Does the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) accurately predict mortality for patients with elevated MELD scores?. The American Journal of Surgery. 224(1). 475–482. 2 indexed citations
5.
Torres, Madeline B., et al.. (2021). Robotic Excision of a Duodenal Gastrointestinal Stromal Tumor. Annals of Surgical Oncology. 28(13). 8977–8978. 1 indexed citations
6.
Torres, Madeline B., Matthew Dixon, & Niraj J. Gusani. (2021). Undertreatment of Pancreatic Cancer. Surgical Oncology Clinics of North America. 31(1). 43–54. 2 indexed citations
7.
Li, Nan, Madeline B. Torres, Ruixue Wang, et al.. (2021). CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Reports Medicine. 2(6). 100297–100297. 34 indexed citations
8.
Torres, Madeline B., et al.. (2021). Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival. Journal of Surgical Oncology. 124(1). 79–87.
9.
Torres, Madeline B., Laurence P. Diggs, Jun S. Wei, et al.. (2021). Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma. Cancer Genetics. 256-257. 21–25. 1 indexed citations
10.
Torres, Madeline B., et al.. (2021). Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology. Annals of Surgical Oncology. 28(6). 3111–3122. 9 indexed citations
11.
Dixon, Matthew, et al.. (2020). Gastric Cancer Treatments and Survival Trends in the United States. Current Oncology. 28(1). 138–151. 11 indexed citations
12.
Torres, Madeline B., et al.. (2020). Venous thromboembolism prevention compliance: A multidisciplinary educational approach utilizing NSQIP best practice guidelines. The American Journal of Surgery. 220(5). 1333–1337. 2 indexed citations
13.
Torres, Madeline B., Justin A. Drake, Jonathan M. Hernandez, et al.. (2020). Trends and Predictors of Failure of Minimally Invasive Surgery for Gastric GIST. Journal of Gastrointestinal Surgery. 25(5). 1319–1322. 3 indexed citations
14.
Torres, Madeline B., et al.. (2020). Upstaging in Early-Stage Pancreatic Cancer: Risk Factors and Effect on Survival. Journal of the American College of Surgeons. 231(4). S173–S174.
15.
Torres, Madeline B., Arghavan Salles, & Amalia Cochran. (2019). Recognizing and Reacting to Microaggressions in Medicine and Surgery. JAMA Surgery. 154(9). 868–868. 157 indexed citations
16.
Li, Nan, Dan Li, Hua Ren, Madeline B. Torres, & Mitchell Ho. (2019). Abstract 2309: Chimeric antigen receptor T-cell therapy targeting glypican-1 in pancreatic cancer. Cancer Research. 79(13_Supplement). 2309–2309. 3 indexed citations
17.
Skarupa, David, Firas Madbak, Madeline B. Torres, et al.. (2019). Prolonged Antibiotics for Drains After Spine Injury Instrumentation for Trauma: Not Prophylactic or Necessary. World Neurosurgery. 128. e552–e555. 4 indexed citations
18.
Li, Dan, Nan Li, Yifan Zhang, et al.. (2018). Development of CAR T cell therapy targeting glypican-3 in liver cancer. Cancer Biology and Medicine. 15. 17. 1 indexed citations
19.
Torres, Madeline B. & Amalia Cochran. (2016). Accuracy and content of medical student midclerkship self-evaluations. The American Journal of Surgery. 211(6). 1153–1157. 6 indexed citations
20.
Hernández, R. Pomés, et al.. (2009). Titanium(IV) complexes: Cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line. Toxicology in Vitro. 24(1). 178–183. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026